within Pharmacolibrary.Drugs.ATC.S;

model S01ED01_1
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00027666666666666665,
    adminDuration  = 600,
    adminMass      = 0.5 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0012,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S01ED01_1</td></tr><td>route:</td><td>ocular</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Timolol is a non-selective beta-adrenergic antagonist used primarily to treat elevated intraocular pressure in ocular conditions such as glaucoma and ocular hypertension. It is also used systemically for hypertension, migraine prophylaxis, and occasionally for arrhythmias. Ophthalmic timolol is widely approved and used today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters following topical ocular administration (ophthalmic solution) in healthy adult volunteers.</p><h4>References</h4><ol><li><p>Fayyaz, A, et al., &amp; Del Amo, EM (2021). Ocular pharmacokinetics of atenolol, timolol and betaxolol cocktail: Tissue exposures in the rabbit eye. <i>European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</i> 166 155–162. DOI:<a href=&quot;https://doi.org/10.1016/j.ejpb.2021.06.003&quot;>10.1016/j.ejpb.2021.06.003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34139290/&quot;>https://pubmed.ncbi.nlm.nih.gov/34139290</a></p></li><li><p>Fayyaz, A, et al., &amp; Del Amo, EM (2020). Topical ocular pharmacokinetics and bioavailability for a cocktail of atenolol, timolol and betaxolol in rabbits. <i>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</i> 155 105553–None. DOI:<a href=&quot;https://doi.org/10.1016/j.ejps.2020.105553&quot;>10.1016/j.ejps.2020.105553</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32946960/&quot;>https://pubmed.ncbi.nlm.nih.gov/32946960</a></p></li><li><p>Fayyaz, A, et al., &amp; Del Amo, EM (2020). Ocular Intracameral Pharmacokinetics for a Cocktail of Timolol, Betaxolol, and Atenolol in Rabbits. <i>Molecular pharmaceutics</i> 17(2) 588–594. DOI:<a href=&quot;https://doi.org/10.1021/acs.molpharmaceut.9b01024&quot;>10.1021/acs.molpharmaceut.9b01024</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31794668/&quot;>https://pubmed.ncbi.nlm.nih.gov/31794668</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S01ED01_1;
